A New Chapter for Oral Precision Therapies in Thyroid Cancer: RET Inhibitors |
01/28/2022 - 8:00am to 9:00am EST |
FLT3 Mutation in Acute Myeloid Leukemia |
02/04/2022 - 8:00am to 9:00am EST |
Multidisciplinary Perspectives in Advanced HCC: A Focus on Immune Checkpoint Inhibitors |
02/11/2022 - 8:00am to 9:00am EST |
Relapsed/Refractory Diffuse Large B-Cell Lymphoma |
02/18/2022 - 8:00am to 9:00am EST |
Evolution of Therapeutics in Aggressive B-Cell Lymphomas |
02/25/2022 - 8:00am to 9:00am EST |
Extranodal Nasal Type NK/T-cell Lymphoma |
03/04/2022 - 8:00am to 9:00am EST |
A Team-Based Approach to Multi-modality Treatment for Early Non-Small Cell Lung Cancer (eNSCLC) in the Era of Immunotherapies |
03/11/2022 - 8:00am to 9:00am EST |
Metastatic Colon Cancer |
03/18/2022 - 8:00am to 9:00am EDT |
Myeloproliferative Neoplasms Update 2022 |
03/25/2022 - 8:00am to 9:00am EDT |
A case of IDH-mutant 1p/19q-codeleted oligodendroglioma |
04/01/2022 - 8:00am to 9:00am EDT |